
Vicky A. Johnson
Examiner (ID: 14814, Phone: (571)272-7106 , Office: P/3656 )
| Most Active Art Unit | 3656 |
| Art Unit(s) | 3656, 3682, 3617 |
| Total Applications | 2307 |
| Issued Applications | 1679 |
| Pending Applications | 145 |
| Abandoned Applications | 512 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18497421
[patent_doc_number] => 20230220055
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-13
[patent_title] => ANTIBODIES TARGETING A GALACTAN-BASED O-ANTIGEN OF K. PNEUMONIAE
[patent_app_type] => utility
[patent_app_number] => 17/820082
[patent_app_country] => US
[patent_app_date] => 2022-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26491
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17820082
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/820082 | ANTIBODIES TARGETING A GALACTAN-BASED O-ANTIGEN OF K. PNEUMONIAE | Aug 15, 2022 | Abandoned |
Array
(
[id] => 19731119
[patent_doc_number] => 12209110
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-01-28
[patent_title] => Chimeric proteins for inducing immunity towards infection with
[patent_app_type] => utility
[patent_app_number] => 17/816145
[patent_app_country] => US
[patent_app_date] => 2022-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 43246
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 125
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17816145
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/816145 | Chimeric proteins for inducing immunity towards infection with | Jul 28, 2022 | Issued |
Array
(
[id] => 18404599
[patent_doc_number] => 20230165950
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-01
[patent_title] => IMMUNOGENIC COMPOSITION COMPRISING CYAA-DERIVED POLYPEPTIDE PROMOTING A TH1/TH17-ORIENTED IMMUNE RESPONSE
[patent_app_type] => utility
[patent_app_number] => 17/814988
[patent_app_country] => US
[patent_app_date] => 2022-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16697
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 123
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17814988
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/814988 | IMMUNOGENIC COMPOSITION COMPRISING CYAA-DERIVED POLYPEPTIDE PROMOTING A TH1/TH17-ORIENTED IMMUNE RESPONSE | Jul 25, 2022 | Abandoned |
Array
(
[id] => 18195537
[patent_doc_number] => 20230049056
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-16
[patent_title] => FimH mutant, compositions therewith and use thereof
[patent_app_type] => utility
[patent_app_number] => 17/814966
[patent_app_country] => US
[patent_app_date] => 2022-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11308
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17814966
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/814966 | FimH mutant, compositions therewith and use thereof | Jul 25, 2022 | Issued |
Array
(
[id] => 18056441
[patent_doc_number] => 20220387527
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-08
[patent_title] => USE OF LACTIC ACID BACTERIA TO TREAT OR PREVENT GESTATIONAL DIABETES MELLITUS
[patent_app_type] => utility
[patent_app_number] => 17/813233
[patent_app_country] => US
[patent_app_date] => 2022-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13487
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17813233
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/813233 | Use of lactic acid bacteria to treat or prevent gestational diabetes mellitus | Jul 17, 2022 | Issued |
Array
(
[id] => 18126560
[patent_doc_number] => 20230012181
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-12
[patent_title] => TREATMENT OF ACUTE AND CHRONIC KIDNEY DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/862295
[patent_app_country] => US
[patent_app_date] => 2022-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9832
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17862295
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/862295 | Treatment of acute and chronic kidney disease | Jul 10, 2022 | Issued |
Array
(
[id] => 20193860
[patent_doc_number] => 20250270570
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-08-28
[patent_title] => QUANTUM-TACTIC YEAST INGREDIENT METHOD FOR OUTBREAK MONITORING WITH RADIOWAVE OPTICS BY SATELLITE ARRAYS ON LAGRANGIAN-1
[patent_app_type] => utility
[patent_app_number] => 18/575741
[patent_app_country] => US
[patent_app_date] => 2022-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4404
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18575741
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/575741 | QUANTUM-TACTIC YEAST INGREDIENT METHOD FOR OUTBREAK MONITORING WITH RADIOWAVE OPTICS BY SATELLITE ARRAYS ON LAGRANGIAN-1 | Jun 28, 2022 | Pending |
Array
(
[id] => 19387909
[patent_doc_number] => 20240277779
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-22
[patent_title] => SKIN CARE NUTRACEUTICAL COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 18/571888
[patent_app_country] => US
[patent_app_date] => 2022-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12463
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 119
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18571888
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/571888 | SKIN CARE NUTRACEUTICAL COMPOSITION | Jun 26, 2022 | Pending |
Array
(
[id] => 19232150
[patent_doc_number] => 20240189341
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-13
[patent_title] => PHARMACEUTICAL COMBINATION AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/011194
[patent_app_country] => US
[patent_app_date] => 2022-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7004
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18011194
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/011194 | PHARMACEUTICAL COMBINATION AND USE THEREOF | Jun 20, 2022 | Pending |
Array
(
[id] => 19387918
[patent_doc_number] => 20240277788
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-22
[patent_title] => COMPOSITIONS FOR INCREASING RESILIENCE TOWARDS BACTERIAL INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 18/570816
[patent_app_country] => US
[patent_app_date] => 2022-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10725
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18570816
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/570816 | COMPOSITIONS FOR INCREASING RESILIENCE TOWARDS BACTERIAL INFECTIONS | Jun 15, 2022 | Pending |
Array
(
[id] => 19343647
[patent_doc_number] => 20240252610
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-01
[patent_title] => A BROADLY PROTECTIVE PROPHYLACTIC VACCINE AGAINST PSEUDOMONAS AERUGINOSA
[patent_app_type] => utility
[patent_app_number] => 18/562170
[patent_app_country] => US
[patent_app_date] => 2022-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28388
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18562170
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/562170 | A BROADLY PROTECTIVE PROPHYLACTIC VACCINE AGAINST PSEUDOMONAS AERUGINOSA | May 22, 2022 | Pending |
Array
(
[id] => 19656868
[patent_doc_number] => 20240423933
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-26
[patent_title] => DRUGS FOR TREATING NEURODEVELOPMENTAL DISORDERS
[patent_app_type] => utility
[patent_app_number] => 18/561989
[patent_app_country] => US
[patent_app_date] => 2022-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9954
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18561989
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/561989 | DRUGS FOR TREATING NEURODEVELOPMENTAL DISORDERS | May 19, 2022 | Pending |
Array
(
[id] => 19571869
[patent_doc_number] => 20240376161
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-14
[patent_title] => RECOMBINANT CHIMERIC PROTEIN, USE THEREOF, AND COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 18/564843
[patent_app_country] => US
[patent_app_date] => 2022-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4858
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18564843
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/564843 | RECOMBINANT CHIMERIC PROTEIN, USE THEREOF, AND COMPOSITION | May 2, 2022 | Pending |
Array
(
[id] => 17836477
[patent_doc_number] => 20220273782
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => Novel PD-L1 Targeting DNA Vaccine for Cancer Immunotherapy
[patent_app_type] => utility
[patent_app_number] => 17/730909
[patent_app_country] => US
[patent_app_date] => 2022-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9856
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17730909
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/730909 | Novel PD-L1 Targeting DNA Vaccine for Cancer Immunotherapy | Apr 26, 2022 | Abandoned |
Array
(
[id] => 19245927
[patent_doc_number] => 20240196908
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-20
[patent_title] => COMPOSITIONS AND METHODS FOR IMPROVING PLANT HEALTH AND CONTROLLING PLANT DISEASE
[patent_app_type] => utility
[patent_app_number] => 18/555946
[patent_app_country] => US
[patent_app_date] => 2022-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37125
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18555946
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/555946 | COMPOSITIONS AND METHODS FOR IMPROVING PLANT HEALTH AND CONTROLLING PLANT DISEASE | Apr 18, 2022 | Pending |
Array
(
[id] => 17760063
[patent_doc_number] => 20220233675
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-28
[patent_title] => VACCINE TO PROTECT A PIG AGAINST ACTINOBACILLUS PLEUROPNEUMONIAE
[patent_app_type] => utility
[patent_app_number] => 17/721115
[patent_app_country] => US
[patent_app_date] => 2022-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3356
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17721115
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/721115 | Vaccine to protect a pig against | Apr 13, 2022 | Issued |
Array
(
[id] => 19256861
[patent_doc_number] => 12016890
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-25
[patent_title] => Composition for preventing or treating menopause, containing
[patent_app_type] => utility
[patent_app_number] => 17/714361
[patent_app_country] => US
[patent_app_date] => 2022-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 9589
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17714361
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/714361 | Composition for preventing or treating menopause, containing | Apr 5, 2022 | Issued |
Array
(
[id] => 17733315
[patent_doc_number] => 20220218774
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-14
[patent_title] => METHOD FOR TREATING A SKIN WOUND HAVING A KLEBSIELLA PNEUMONIAE INFECTION
[patent_app_type] => utility
[patent_app_number] => 17/707132
[patent_app_country] => US
[patent_app_date] => 2022-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16953
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17707132
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/707132 | Method for treating a skin wound having a | Mar 28, 2022 | Issued |
Array
(
[id] => 17748252
[patent_doc_number] => 20220226455
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-21
[patent_title] => VACCINE AGAINST NECROTIC ENTERITIS IN POULTRY
[patent_app_type] => utility
[patent_app_number] => 17/705913
[patent_app_country] => US
[patent_app_date] => 2022-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10563
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 130
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17705913
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/705913 | VACCINE AGAINST NECROTIC ENTERITIS IN POULTRY | Mar 27, 2022 | Abandoned |
Array
(
[id] => 20057422
[patent_doc_number] => 20250195644
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-06-19
[patent_title] => Compositions For and Methods of Preventing Metastases
[patent_app_type] => utility
[patent_app_number] => 18/548918
[patent_app_country] => US
[patent_app_date] => 2022-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42277
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18548918
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/548918 | Compositions For and Methods of Preventing Metastases | Mar 3, 2022 | Pending |